Search

Keli L. Hill

Examiner (ID: 14362, Phone: (571)272-4375 , Office: P/2912 )

Most Active Art Unit
2912
Art Unit(s)
2912, 2922, 2952
Total Applications
3649
Issued Applications
3514
Pending Applications
12
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6213880 [patent_doc_number] => 20110136742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'ANTIDEPRESSANT PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/280190 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5128 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136742.pdf [firstpage_image] =>[orig_patent_app_number] => 12280190 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/280190
ANTIDEPRESSANT PRODRUGS Feb 21, 2007 Abandoned
Array ( [id] => 4977258 [patent_doc_number] => 20070218491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Oligomerization of amyloid proteins' [patent_app_type] => utility [patent_app_number] => 11/704079 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6917 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218491.pdf [firstpage_image] =>[orig_patent_app_number] => 11704079 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/704079
Oligomerization of amyloid proteins Feb 7, 2007 Abandoned
Array ( [id] => 5004984 [patent_doc_number] => 20070202554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Method for determining degree of negative effect of macrophages on vertebrate' [patent_app_type] => utility [patent_app_number] => 11/699018 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2887 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202554.pdf [firstpage_image] =>[orig_patent_app_number] => 11699018 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/699018
Method for determining degree of negative effect of macrophages on vertebrate Jan 28, 2007 Issued
Array ( [id] => 4846376 [patent_doc_number] => 20080182784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/627005 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20850 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182784.pdf [firstpage_image] =>[orig_patent_app_number] => 11627005 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/627005
Methods and compositions for treating neurological disorders Jan 24, 2007 Issued
Array ( [id] => 5580526 [patent_doc_number] => 20090175872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Treatment of Conditions Involving Demyelination' [patent_app_type] => utility [patent_app_number] => 12/095857 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 49491 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175872.pdf [firstpage_image] =>[orig_patent_app_number] => 12095857 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095857
Treatment of Conditions Involving Demyelination Nov 30, 2006 Abandoned
Array ( [id] => 6425421 [patent_doc_number] => 20100151451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Method for Identifying the Genotype in Position 171 of the Ovine Prion Protein as well as Kits for Implementing said Method' [patent_app_type] => utility [patent_app_number] => 12/095058 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10708 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151451.pdf [firstpage_image] =>[orig_patent_app_number] => 12095058 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095058
Method for Identifying the Genotype in Position 171 of the Ovine Prion Protein as well as Kits for Implementing said Method Nov 23, 2006 Abandoned
Array ( [id] => 5435572 [patent_doc_number] => 20090170159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'PRODUCTION OF GLYCOPROTEINS WITH REDUCED O-GLYCOSYLATION' [patent_app_type] => utility [patent_app_number] => 12/084591 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14772 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170159.pdf [firstpage_image] =>[orig_patent_app_number] => 12084591 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/084591
Production of glycoproteins with reduced O-glycosylation Nov 9, 2006 Issued
Array ( [id] => 5130755 [patent_doc_number] => 20070207152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Human BNP immunospecific antibodies' [patent_app_type] => utility [patent_app_number] => 11/595625 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 30277 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207152.pdf [firstpage_image] =>[orig_patent_app_number] => 11595625 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/595625
Human BNP immunospecific antibodies Nov 8, 2006 Abandoned
Array ( [id] => 91778 [patent_doc_number] => 07732201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Method for production of neuroblasts' [patent_app_type] => utility [patent_app_number] => 11/592504 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 17 [patent_no_of_words] => 13940 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732201.pdf [firstpage_image] =>[orig_patent_app_number] => 11592504 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/592504
Method for production of neuroblasts Nov 2, 2006 Issued
Array ( [id] => 5183607 [patent_doc_number] => 20070054961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Factor' [patent_app_type] => utility [patent_app_number] => 11/526458 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21272 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054961.pdf [firstpage_image] =>[orig_patent_app_number] => 11526458 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/526458
Factor Sep 24, 2006 Abandoned
Array ( [id] => 5095513 [patent_doc_number] => 20070117122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methods of diagnosing or prognosticating age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 11/526188 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12491 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117122.pdf [firstpage_image] =>[orig_patent_app_number] => 11526188 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/526188
Methods of diagnosing or prognosticating age-related macular degeneration Sep 24, 2006 Abandoned
Array ( [id] => 5074819 [patent_doc_number] => 20070014794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'METHOD FOR MAKING HETEROMULTIMERIC POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/533709 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22619 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014794.pdf [firstpage_image] =>[orig_patent_app_number] => 11533709 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/533709
Knobs and holes heteromeric polypeptides Sep 19, 2006 Issued
Array ( [id] => 7795370 [patent_doc_number] => 08124076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Single chain antibodies against β-amyloid peptide' [patent_app_type] => utility [patent_app_number] => 12/064144 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 6658 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124076.pdf [firstpage_image] =>[orig_patent_app_number] => 12064144 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/064144
Single chain antibodies against β-amyloid peptide Aug 17, 2006 Issued
Array ( [id] => 5662504 [patent_doc_number] => 20060253100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Systems and Methods to Treat Pain Locally' [patent_app_type] => utility [patent_app_number] => 11/460012 [patent_app_country] => US [patent_app_date] => 2006-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8126 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20060253100.pdf [firstpage_image] =>[orig_patent_app_number] => 11460012 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/460012
Systems and Methods to Treat Pain Locally Jul 25, 2006 Abandoned
Array ( [id] => 5570240 [patent_doc_number] => 20090253618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'NEURONAL DIFFERENTIATION-INDUCING PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/996207 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9469 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253618.pdf [firstpage_image] =>[orig_patent_app_number] => 11996207 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996207
NEURONAL DIFFERENTIATION-INDUCING PEPTIDE AND USE THEREOF Jul 19, 2006 Abandoned
Array ( [id] => 4711678 [patent_doc_number] => 20080300204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Alpha-Synuclein Antibodies and Methods Related Thereto' [patent_app_type] => utility [patent_app_number] => 11/996262 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27771 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300204.pdf [firstpage_image] =>[orig_patent_app_number] => 11996262 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996262
Alpha-Synuclein Antibodies and Methods Related Thereto Jul 18, 2006 Abandoned
Array ( [id] => 5022696 [patent_doc_number] => 20070148662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 11/480319 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12724 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148662.pdf [firstpage_image] =>[orig_patent_app_number] => 11480319 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/480319
Prostate-specific membrane antigen Jun 29, 2006 Abandoned
Array ( [id] => 7683787 [patent_doc_number] => 20100122354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/993122 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17847 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20100122354.pdf [firstpage_image] =>[orig_patent_app_number] => 11993122 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/993122
CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE Jun 19, 2006 Abandoned
Array ( [id] => 6212329 [patent_doc_number] => 20110135629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/993130 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17846 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135629.pdf [firstpage_image] =>[orig_patent_app_number] => 11993130 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/993130
EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use Jun 19, 2006 Abandoned
Array ( [id] => 6367886 [patent_doc_number] => 20100074884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'INHIBITION OF NEURONAL DAMAGE' [patent_app_type] => utility [patent_app_number] => 11/916237 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8933 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074884.pdf [firstpage_image] =>[orig_patent_app_number] => 11916237 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/916237
INHIBITION OF NEURONAL DAMAGE May 30, 2006 Abandoned
Menu